FDA Approves Generic Version of Nexium
The U.S. Food and Drug Administration today approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to treat gastroesophageal reflux disease (GERD) in adults and children ages 1 and older.
Antacids May Extend Some Cancer Patients' Lives
Antacids may help with more than just heartburn. They could help some cancer patients live longer.
Getting the Right Rx Dose to Treat GERD
Treating gastric reflux with over-the-counter (OTC) medication might not bring relief, even though the medications might be similar to the prescription brands.
Treatment Lowered Cancer Risk of Barrett’s Esophagus
Barrett's esophagus is more than a bad case of indigestion. In fact, it can even lead to cancer. But a new study shows a promising treatment that may greatly reduce that risk.
Surgery Might Not Mean End of Acid Reflux
Anti-reflux surgery should relieve symptoms and break dependence on medication, right?
Weight-Loss Surgeries Not Created Equal for Heartburn Patients
Surgery to help with weight loss is becoming more common and more varied, but these surgeries might not help with every weight-related issue, a new study says.
Acid Reducing Meds Linked to Low Vitamin B12 Levels
It's relatively common for older folks to have low levels of vitamin B12. According to a new study, certain medications may contribute to these low vitamin levels.
Avoiding Cancer with Barrett's Esophagus
Barrett's esophagus occurs when cells of the esophagus change over time to resemble cells of the intestine, and the condition can put patients at risk of cancer. Researchers have found that one type of medication may lower this risk.
Handling Heartburn During the Holidays
During the holidays, there's plenty to consider, especially when it comes to planning meals and get-togethers. With all those meals, another major concern for some might be how to avoid heartburn.
FDA Approves First Generic Versions of Aciphex Delayed-Release Tablets to Treat GERD
The US Food and Drug Administration today approved the first generic versions of Aciphex (rabeprazole sodium) delayed-release tablets, used to treat gastroesophageal reflux disease (GERD) in adults and adolescents (ages 12 and up).